Manner of identification of MDR TB and reasons for, and duration of, delay in starting appropriate MDR TB treatment
| Manner of identification and/or reason for delay* | No. (%) | Delay in days, median (range) |
|---|---|---|
| *Some children represented in more than one group. | ||
| Household MDR TB source cases known at time of diagnosis | ||
| MDR TB treatment from TB diagnosis | 9 (23) | 2 (0–45) |
| Child not managed as MDR contact | 11 (28%) | 246 (77–1537) |
| Community contact MDR identified after MDR culture result | 2 (5) | |
| Response to culture/susceptibility result only (2 MDR contacts) | 10 (26) | 77 (37–176) |
| Poor response (deterioration or relapse) despite treatment for drug susceptible TB (including isoniazid and rifampicin) | ||
| Initial MDR result disregarded | 3 (8) | 294 (281–590) |
| Culture/susceptibility done in response to deterioration | 11 (28) | 263 (103–1537) |
| MDR confirmed culture, but no MDR treatment [untraceable (2) or clinically well when traced (1)] | 3 (8) | |